{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:fda-pcac-peptide-review-meeting:v1","objectPathId":"fda-pcac-peptide-review-meeting-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/fda-pcac-peptide-review-meeting/","json":"https://peptidescanner.com/evidence/v1/objects/fda-pcac-peptide-review-meeting-v1.json","markdown":"https://peptidescanner.com/evidence/v1/objects/fda-pcac-peptide-review-meeting-v1.md"},"story":{"slug":"fda-pcac-peptide-review-meeting","version":1,"domain":"Regulatory","dateInSource":"2026-07-24","sourceCheckedAt":"2026-07-29","publishedAt":"2026-07-29","peptideSlugs":["bpc-157","emideltide","epitalon","kpv","mots-c","semax","tb-500"],"peptides":[{"slug":"bpc-157","url":"https://peptidescanner.com/peptides/bpc-157/"},{"slug":"emideltide","url":"https://peptidescanner.com/peptides/emideltide/"},{"slug":"epitalon","url":"https://peptidescanner.com/peptides/epitalon/"},{"slug":"kpv","url":"https://peptidescanner.com/peptides/kpv/"},{"slug":"mots-c","url":"https://peptidescanner.com/peptides/mots-c/"},{"slug":"semax","url":"https://peptidescanner.com/peptides/semax/"},{"slug":"tb-500","url":"https://peptidescanner.com/peptides/tb-500/"}]},"claims":[{"id":"headline","text":"FDA committee met on seven peptide-related groups of bulk drug substances","sourceIds":["fda-pcac-peptide-meeting-2026"]},{"id":"summary","text":"FDA convened its Pharmacy Compounding Advisory Committee on July 23-24, 2026, to discuss free-base and acetate bulk drug substances across seven peptide-related groups.","sourceIds":["fda-pcac-peptide-meeting-2026"]},{"id":"paragraph-1","text":"FDA's meeting page groups the discussed bulk drug substances under BPC-157, emideltide, epitalon, KPV, MOTS-c, Semax, and TB-500 and lists free-base and acetate forms for each of those seven peptide-related groups.","sourceIds":["fda-pcac-peptide-meeting-2026"]},{"id":"paragraph-2","text":"FDA's briefing documents say advisory-committee recommendations are nonbinding and that FDA will make final determinations only after completing the committee process and relevant reviews. This update reports the meeting, not a final FDA decision on any substance.","sourceIds":["fda-bpc-157-briefing","fda-emideltide-briefing","fda-epitalon-briefing","fda-kpv-briefing","fda-mots-c-briefing","fda-semax-briefing","fda-tb-500-briefing"]}],"sources":[{"id":"fda-pcac-peptide-meeting-2026","name":"U.S. Food and Drug Administration","sourceClass":"A","title":"July 23-24, 2026 Pharmacy Compounding Advisory Committee meeting","url":"https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026"},{"id":"fda-bpc-157-briefing","name":"U.S. Food and Drug Administration","sourceClass":"A","title":"FDA briefing document for BPC-157-related bulk drug substances","url":"https://www.fda.gov/media/193343/download"},{"id":"fda-emideltide-briefing","name":"U.S. Food and Drug Administration","sourceClass":"A","title":"FDA briefing document for emideltide (DSIP) (free base) and emideltide acetate","url":"https://www.fda.gov/media/193344/download"},{"id":"fda-epitalon-briefing","name":"U.S. Food and Drug Administration","sourceClass":"A","title":"FDA briefing document for epitalon","url":"https://www.fda.gov/media/193345/download"},{"id":"fda-kpv-briefing","name":"U.S. Food and Drug Administration","sourceClass":"A","title":"FDA briefing document for KPV","url":"https://www.fda.gov/media/193346/download"},{"id":"fda-mots-c-briefing","name":"U.S. Food and Drug Administration","sourceClass":"A","title":"FDA briefing document for MOTS-c","url":"https://www.fda.gov/media/193347/download"},{"id":"fda-semax-briefing","name":"U.S. Food and Drug Administration","sourceClass":"A","title":"FDA briefing document for Semax","url":"https://www.fda.gov/media/193348/download"},{"id":"fda-tb-500-briefing","name":"U.S. Food and Drug Administration","sourceClass":"A","title":"FDA briefing document for TB-500","url":"https://www.fda.gov/media/193349/download"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"5f2de7a01f4de0441433d139f270cf2dba965aa3a1ad985b18864ed2166d7d6f"},"integrity":{"algorithm":"sha256","contentSha256":"65097e7b6e0a9f128007ed9a4a1fb1b9a974c63e39ed02f4c43e1c5741807d3d"}}